These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 2847867

  • 1. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.
    Sakamoto M, Hirohashi S, Tsuda H, Ino Y, Shimosato Y, Yamasaki S, Makuuchi M, Hasegawa H, Terada M, Hosoda Y.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7294-7. PubMed ID: 2847867
    [Abstract] [Full Text] [Related]

  • 2. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 15; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 3. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 15; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 4. [Hepatitis C infection and liver cell carcinoma].
    Maier KP.
    Schweiz Rundsch Med Prax; 1992 Aug 18; 81(34):978-9. PubMed ID: 1382306
    [Abstract] [Full Text] [Related]

  • 5. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X, Park YN, Taltavull TC, Thung SN, Jin X, Jin Y, Trung NS, Edamoto Y, Sata T, Abe K.
    Jpn J Infect Dis; 2003 Feb 18; 56(1):12-8. PubMed ID: 12711820
    [Abstract] [Full Text] [Related]

  • 6. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 18; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 Sep 18; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E.
    J Med Virol; 2003 May 18; 70(1):20-6. PubMed ID: 12629639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 18; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 13. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ.
    Schweiz Med Wochenschr; 1986 Aug 23; 116(34):1133-45. PubMed ID: 3020684
    [Abstract] [Full Text] [Related]

  • 14. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar 23; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H, Obata H, Motoike Y, Hisamitsu T.
    Hepatogastroenterology; 1984 Apr 23; 31(2):64-8. PubMed ID: 6202615
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Apr 23; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.